about
Metabolic syndrome, diabetes, and cardiovascular risk in HIVRelationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United StatesHIV protease inhibitor exposure predicts cerebral small vessel disease.Comparison of Serum Lipid Profile in HIV Positive Patients on ART with ART Naïve Patients.HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infectionBrain morphometric correlates of metabolic variables in HIV: the CHARTER study.Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks.The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyFirst-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Management of dyslipidemia in HIV-infected patients.Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of CameroonEffects of a Low Dose of Fish Oil on Inflammatory Markers of Brazilian HIV-Infected Adults on Antiretroviral Therapy: A Randomized, Parallel, Placebo-Controlled TrialDyslipidaemia in HIV-1-infected patients receiving protease inhibitors after initial treatment with first-line-based non-nucleoside reverse transcriptase inhibitors: a cross-sectional study.Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART.Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group studyCardiometabolic risk factors among HIV patients on antiretroviral therapy.HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort studyPrimary care of women aging with HIV.Malnutrition and lipid abnormalities in antiretroviral naïve HIV-infected adults in Addis Ababa: A cross-sectional study.Insulin Resistance in HIV-Patients: Causes and Consequences
P2860
Q26853470-8C66DFC6-BA8B-4B07-B6B6-A31C0FFB541EQ33590784-234A17D5-460B-4A5E-9CA7-A128BC6E815CQ33807507-D5C51888-703F-4F29-A4C3-50D62B5B3545Q34617937-5DE92BF0-77E8-4B79-94DA-286A1D3139CCQ34712485-3BBA1E79-BDBC-4E6A-B3CF-01CF402F1390Q34716740-9112CEDC-A5A0-43B2-B526-06C6F14BDA25Q35103606-282D2098-91D1-438D-9B5B-F9C5B4CF79DCQ35114120-82CD67A0-AC27-48E3-ACF9-F4F4CECB1F8FQ35142495-9E4BE5E8-706A-408D-9DBF-88D908C5709AQ35148082-C6124F55-0A84-4F59-B8EF-92ECB14B73A7Q35185674-D214B39F-F01B-4D16-9880-5BC1D8239C12Q35397077-1E767175-C7B3-4442-9EBC-89A183644AD7Q35567828-0C0A3F6B-3095-4BAA-B499-75FF9020ABF5Q35643573-8A3BA61F-D313-4BAF-BBD2-E97959D6160CQ35758159-163B03D3-3FD7-4BB9-9C72-038326DD4087Q36012395-E0F70AD2-3409-4B49-AACF-BB333092DAA9Q36184035-322FD9B7-9520-452F-8090-4855056C3799Q36282430-AFE3E52F-FE8C-4996-86A9-189FAD994B3DQ36402308-E6C50590-73DF-4DC9-9AEE-958E853B6FC3Q36808820-68F6E983-1D62-4F86-A206-2466117A1A87Q36842181-5EF600B2-6953-4B51-92CB-8CE72A21A7B4Q37272968-D8D9EF6C-4013-42B3-B944-08891AD1B5A4Q53691588-A83F39CF-7EE3-4871-BA37-02FE8F7A53AFQ58763014-9138B0C5-3D28-4B54-B244-58664B968F60
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dyslipidemia and its Treatment in HIV Infection.
@ast
Dyslipidemia and its Treatment in HIV Infection.
@en
type
label
Dyslipidemia and its Treatment in HIV Infection.
@ast
Dyslipidemia and its Treatment in HIV Infection.
@en
prefLabel
Dyslipidemia and its Treatment in HIV Infection.
@ast
Dyslipidemia and its Treatment in HIV Infection.
@en
P2860
P1476
Dyslipidemia and its Treatment in HIV Infection.
@en
P2093
Carl Grunfeld
P2860
P304
P577
2010-08-01T00:00:00Z